Clinical trial
Immune Tolerance Induction in Haemophilia A Patients Using Wilate or Nuwiq - A Canadian Study
NCT03344003 is registered in ClinicalTrials.gov with Octapharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immune Tolerance Induction in Haemophilia A Patients Using Wilate or Nuwiq - A Canadian Study
- Lead sponsor
- Octapharma
- Phase
- Observational
- Overall status
- Terminated
- Start date
- June 28, 2018
- Completion date
- November 20, 2020
- Enrollment
- 14 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.